Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Kit formulation of Bevacizumab...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies
Bibliographic Details
Main Authors:
Bouziotis, P
,
Gourni, E
,
Xanthopoulos, S
,
Paravatou, M
,
Syrigos, K
,
Loudos, G
,
Archimandritis, S
,
Varvarigou, A
,
Harris, A
Format:
Journal article
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
by: Janke Kleynhans, et al.
Published: (2023-02-01)
Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
by: A. O. Malysheva, et al.
Published: (2022-11-01)
SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
by: G. E. Kodina, et al.
Published: (2019-01-01)
Conjugation, labelling and in vitro/in vivo assessment of an anti-VEGF monoclonal antibody labelled with niobium isotopes
by: De La Fuente, A, et al.
Published: (2018)
Development of bevacizumab-conjugated ferromagnetic nanoparticles for non-invasive angiogenesis detection
by: Bouziotis, P, et al.
Published: (2009)